<Version><xmlsource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlsource><Section SecID="390" OrdBy="100" Name="General"><Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text"><FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Food and nutrition for older adults promoting health and wellness (FNOA).&lt;/div&gt;" /></Field><Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Academy of Nutrition and Dietetics. Food and nutrition for older adults promoting health and wellness. Chicago (IL): Academy of Nutrition and Dietetics; 2012. Various p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field Name ="UMLS Concepts"><FieldValue Value="ICD9CM: Alzheimer's disease  (331.0); Macular degeneration (senile), unspecified  (362.50); Mild cognitive impairment, so stated  (331.83); Obesity, unspecified  (278.00); Overweight  (278.02); Screening for obesity  (V77.8)"/><FieldValue Value="MSH: Alzheimer Disease ; Body Composition ; Body Mass Index ; Body Weight ; Cognition Disorders ; Diet Therapy ; Eligibility Determination ; Geriatric Assessment ; Government Programs ; Health Promotion ; Health Services for the Aged ; Macular Degeneration ; Minerals ; Motor Activity ; Nutrition Assessment ; Nutrition Therapy ; Obesity ; Overweight ; Patient Care Team ; Vitamins ; Waist Circumference "/><FieldValue Value="MTH: Age related macular degeneration ; Alzheimer's Disease ; Body mass index procedure ; Body Weight ; Cognition Disorders ; Diet therapy ; Encounter due to screening for obesity ; Impaired cognition ; Minerals ; Nutrition Assessment ; Nutrition Therapy ; Obesity ; Obesity screen ; OVERWEIGHT ; Physical activity ; Vitamins ; Weight maintenance regimen "/><FieldValue Value="PDQ: obesity "/><FieldValue Value="SNOMEDCT_US: Age related macular degeneration  (267718000); Alzheimer's disease  (26929004); Antioxidant vitamin-rich diet  (226154003); Assessment of nutritional status  (1759002); Assessment of nutritional status  (310243009); Body composition  (68592003); Body weight  (27113001); Cognitive disorder  (443265004); Geriatric screening  (171313004); Health promotion  (171434007); Impaired cognition  (386806002); Mineral  (87918000); Nutrition therapy  (386373004); Obesity  (414915002); Obesity  (414916001); Obesity screening  (268551005); Overweight  (238131007); Physical activity  (48761009); Physical activity  (68130003); Vitamin  (12968008); Vitamin  (87708000); Waist circumference  (276361009); Weight maintenance regimen  (388962008)"/></Field></Section><Section SecID="396" OrdBy="300" Name="Scope"><Field FieldID="140" OrdBy="305" ID="397" Name="Disease/Condition(s)" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Health and wellness &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cognitive impairment &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Age-related macular degeneration &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="103" OrdBy="310" ID="398" Name="Guideline Category" Type="picklist-many"><FieldValue Value="Counseling" /><FieldValue Value="Diagnosis" /><FieldValue Value="Evaluation" /><FieldValue Value="Management" /><FieldValue Value="Prevention" /><FieldValue Value="Screening" /><FieldValue Value="Treatment" /></Field><Field FieldID="113" OrdBy="315" ID="399" Name="Clinical Specialty" Type="picklist-many"><FieldValue Value="Family Practice" /><FieldValue Value="Geriatrics" /><FieldValue Value="Neurology" /><FieldValue Value="Nursing" /><FieldValue Value="Nutrition" /><FieldValue Value="Ophthalmology" /><FieldValue Value="Optometry" /><FieldValue Value="Preventive Medicine" /><FieldValue Value="Psychiatry" /><FieldValue Value="Psychology" /></Field><Field FieldID="114" OrdBy="320" ID="400" Name="Intended Users" Type="picklist-many"><FieldValue Value="Advanced Practice Nurses" /><FieldValue Value="Allied Health Personnel" /><FieldValue Value="Dentists" /><FieldValue Value="Dietitians" /><FieldValue Value="Health Care Providers" /><FieldValue Value="Hospitals" /><FieldValue Value="Managed Care Organizations" /><FieldValue Value="Nurses" /><FieldValue Value="Occupational Therapists" /><FieldValue Value="Optometrists" /><FieldValue Value="Pharmacists" /><FieldValue Value="Physical Therapists" /><FieldValue Value="Physician Assistants" /><FieldValue Value="Physicians" /><FieldValue Value="Psychologists/Non-physician Behavioral Health Clinicians" /><FieldValue Value="Public Health Departments" /><FieldValue Value="Social Workers" /></Field><Field FieldID="129" OrdBy="325" ID="401" Name="Guideline Objective(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Overall Objective&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;To provide evidence-based recommendations on three topics related to food and nutrition for older adults promoting health and wellness&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Specific Objectives&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;To define evidence-based nutrition recommendations for registered dietitians (RDs) that are carried out in collaboration with other healthcare providers &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To guide practice decisions that integrate medical, nutritional and behavioral strategies &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To reduce variations in practice among RDs &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To provide the RD with data to make recommendations to adjust medical nutrition therapy (MNT) or recommend other therapies to achieve desired outcomes &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To develop guidelines for interventions that have measurable clinical outcomes &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To define the highest quality of care within cost constraints of the current healthcare environment &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="132" OrdBy="330" ID="402" Name="Target Population" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Older adults (aged 60 years and older)&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="133" OrdBy="335" ID="403" Name="Interventions and Practices Considered" Type="text"><FieldValue Value="&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;Assessing the need for weight management through modifications in dietary intake and physical activity &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Use of multiple assessment indicators for classification of overweight/obesity&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Weight change (and weight history) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Current (and past) weight, height and body mass index (BMI) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Waist circumference &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Body composition &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Screening for eligibility for and encouraging participation in United States Department of Agriculture (USDA) and Older Americans Act (OAA) Nutrition Service programs &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Encouraging food intake meeting the Dietary Reference Intakes (or other recommended levels) for antioxidant vitamins and minerals and recommending a multi-vitamin if food intake is low &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Collaborating with others on the inter-professional team to determine whether individuals diagnosed with age-related macular degeneration would benefit from high-dose supplementation of antioxidants &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Advising against antioxidants for treatment of diagnosed cognitive impairment/Alzheimer's disease &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;" /></Field><Field FieldID="134" OrdBy="340" ID="404" Name="Major Outcomes Considered" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Physical function &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Changes in age-related macular degeneration (improvement or progression) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cognition levels &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Mortality &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="405" OrdBy="400" Name="Methodology"><Field FieldID="109" OrdBy="405" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many"><FieldValue Value="Searches of Electronic Databases" /></Field><Field FieldID="135" OrdBy="410" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;General Methods for Collecting/Selecting the Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The following list provides an overview of the steps which the Academy evidence analysis team goes through to identify research through database searches.&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot; start=&quot;1&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Plan the search strategy&lt;/strong&gt; to identify the &quot;current best evidence&quot; relevant to the question. The plan for identification and inclusion of articles and reports should be systematic and reproducible, not haphazard. Write out the original search strategy and document adjustments to the strategy if they occur. Allow for several iterations of searches. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;List inclusion and exclusion criteria&lt;/strong&gt;. The workgroup will define the inclusion and exclusion criteria. These criteria will be used in defining the search strategy and for filtering the identified research reports. The Academy uses only peer-reviewed research; that is, articles accepted for evidence analysis must be peer-reviewed and published in a juried publication. Additionally, the Academy only uses human subjects in its research and does not include animal studies in its evidence analysis. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Identify search words&lt;/strong&gt;. During the process of considering outcomes, interventions, nutrition diagnoses, and assessments, the work group may have identified a number of specific terms or factors that were important, but were not included in the actual question. These terms can be used as additional search terms to help identify relevant pieces of research. Both text word search and keyword search using Medical Subject Headings (MeSH) definitions may be used. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Identify databases to search&lt;/strong&gt;. PubMed, Medline, CINAHL, EMBASE, Cochrane, Agricola, DARE, TRIP, AHRQ and ERIC are some common databases for clinical nutritional research. Note that search terms can vary depending on the database. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Conduct the search&lt;/strong&gt;. Depending on the number and type of sources found in the initial search, adjustments might have to be made in the search strategy and to inclusion/exclusion criteria, and additional searches run. Changes to the search plan should be recorded for future reference. Document the number of sources identified in each search. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Review titles and abstracts&lt;/strong&gt;. At this point, a filtering procedure is used to determine whether a research article matches the inclusion criteria and is relevant to the work group's questions. Typically, the lead analyst, along with a member of the expert workgroup, first reviews the citations and abstracts to filter out reports that are not applicable to the question. If a determination cannot be made based on the citation and abstract, then the full text of the article is obtained for review. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Gather all remaining articles and reports&lt;/strong&gt;. Obtain paper or electronic copies of research articles that remain on the list following the citation and abstract review. If there are less than six citations, it could mean that the search was too specific to identify relevant research or that research has not been done on this topic. A broadened search should be tried. When there is a long list of citations, ascertain whether it includes articles that are tangential to the question or address the question in only a general way. In this case a more focused search strategy may be necessary. &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Specific Methods for This Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The recommendations in the guideline were based on a systematic review of the literature. Searches of PubMed database were performed on the following topics:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Weight management in older adults &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;United States Department of Agriculture (USDA) an Older Americans Act (OAA) programs in older adults &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Antioxidant consumption and age-related macular degeneration and cognitive function in older adults &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Each evidence analysis topic has a link to supporting evidence in the original guideline, where the Search Plan and Results can be found. Here the reader can view when the search plan was performed, specific inclusion and exclusion criteria, search terms, data bases that were searched, and the excluded articles.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="136" OrdBy="415" ID="408" Name="Number of Source Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not stated&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="115" OrdBy="420" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice"><FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" /></Field><Field FieldID="149" OrdBy="425" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Conclusion Grading Table&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Conclusion Grading Table&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Strength of Evidence Elements&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade I&lt;br /&gt;&#xD;&#xA;            Good/Strong&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade II&lt;br /&gt;&#xD;&#xA;            Fair&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade III&lt;br /&gt;&#xD;&#xA;            Limited/Weak&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade IV&lt;br /&gt;&#xD;&#xA;            Expert Opinion Only&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade V&lt;br /&gt;&#xD;&#xA;            Grade Not Assignable&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Quality&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Scientific rigor/validity &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Considers design and execution &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of strong design for question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Free from design flaws, bias and execution problems &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of strong design for question with minor methodological concerns&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Only studies of weaker study design for question&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of weak design for answering the question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Inconclusive findings due to design flaws, bias or execution problems&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No studies available&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Conclusion based on usual practice, expert consensus, clinical experience, opinion, or extrapolation from basic research &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No evidence that pertains to question being addressed &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Consistency&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Of findings across studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Findings generally consistent in direction and size of effect or degree of association, and statistical significance with minor exceptions at most&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Inconsistency among results of studies with strong design&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Consistency with minor exceptions across studies of weaker designs&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Unexplained inconsistency among results from different studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Single study unconfirmed by other studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Conclusion supported solely by statements of informed nutrition or medical commentators&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;NA&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Quantity&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Number of studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Number of subjects in studies &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;One to several good quality studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Large number of subjects studied&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Studies with negative results having sufficiently large sample size for adequate statistical power&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Several studies by independent investigators&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Doubts about adequacy of sample size to avoid Type I and Type II error &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Limited number of studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Low number of subjects studied and/or inadequate sample size within studies &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Unsubstantiated by published studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Relevant studies have not been done&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Clinical Impact&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Importance of studied outcomes &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Magnitude of effect &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied outcome relates directly to the question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Size of effect is clinically meaningful&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Significant (statistical) difference is large &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Some doubt about the statistical or clinical significance of effect&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied outcome is an intermediate outcome or surrogate for the true outcome of interest&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Size of effect is small or lacks statistical and/or clinical significance&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Objective data unavailable&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Indicates area for future research&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Generalizability&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            To population of interest&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied population, intervention and outcomes are free from serious doubts about generalizability&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Minor doubts about generalizability&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Serious doubts about generalizability due to narrow or different study population, intervention or outcomes studied&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Generalizability limited to scope of experience&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;NA&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;This grading system was based on the grading system from Greer, Mosser, Logan, &amp;amp; Wagstrom Halaas. A practical approach to evidence grading. Jt Comm J Qual Improv. 2000;26:700-712. In September 2004, The ADA Research Committee modified the grading system to this current version.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="116" OrdBy="430" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many"><FieldValue Value="Systematic Review with Evidence Tables" /></Field><Field FieldID="150" OrdBy="435" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Step 1: Formulate Evidence Analysis Question&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Specify a question in a defined area of practice; or state a tentative conclusion or recommendation that is being considered. Include the patient type and special needs of the target population involved, the alternatives under consideration, and the outcomes of interest (PICO format).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Step 2: Gather and Classify Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Conduct a systematic search of the literature to find evidence related to the question, gather studies and reports, and classify them by type of evidence. Classes differentiate primary reports of new data according to study design, and distinguish them from secondary reports that include systematic and/or narrative review.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Step 3: Critically Appraise Each Article&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Review each article for relevance to the question and use the checklist of questions to evaluate the research design and implementation. Abstract key information from the report.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Step 4: Summarize Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Synthesize the reports into an overview table and summarize the research relevant to the question.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Step 5: Write and Grade the Conclusion Statement&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Develop a concise conclusion statement (the answer to the question). Assign a grade to indicate the overall strength or weakness of evidence informing the conclusion statement (see the &quot;Rating Scheme for the Strength of the Evidence&quot; field).&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="112" OrdBy="440" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice"><FieldValue Value="Expert Consensus" /></Field><Field FieldID="145" OrdBy="445" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Moving from Analysis to the Evidence-Based Nutrition Practice Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The expert work group, which includes practitioners and researchers with a depth of experience in the specific field of interest, develops the disease-specific guideline. The guideline development involves the following steps:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Review the Conclusion Statements&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The work group meets to review the materials resulting from the evidence analysis, which may include conclusion statements, evidence summaries, and evidence worksheets.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Formulate Recommendations for the Guideline Integrating Conclusions from Evidence Analysis&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The work group uses an expert consensus method to formulate the guideline recommendations and complete the various sections on the recommendation page. These include:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Recommendation(s)&lt;/strong&gt;: This is a course of action for the practitioner. The recommendation is written using two brief and separate statements. The first statement is &quot;what&quot; the dietitian should do or not do. The second statement describes the &quot;why&quot; of the recommendation. More than one recommendation may be formulated depending on a particular topic and the supporting conclusion statements. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Rating&lt;/strong&gt;: The rating for the recommendation is based on the strength of the supporting evidence. The grade of the supporting conclusion statement(s) will be help determining this rating (see the &quot;Rating Scheme for the Strength of the Recommendations&quot; field). &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Label of Conditional or Imperative&lt;/strong&gt;: Each recommendation will have a label of &quot;conditional&quot; or &quot;imperative.&quot; Conditional statements clearly define a specific situation, while imperative statements are broadly applicable to the target population without restraints on their pertinence. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Risks and Harms of Implementing the Recommendations&lt;/strong&gt;: Includes any potential risks, anticipated harms or adverse consequences associated with applying the recommendation(s) to the target population. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Conditions of Application&lt;/strong&gt;: Includes any organizational barriers or changes that would need to be made within an organization to apply the recommendation in daily practice. Also includes any conditions which may limit the application of the recommendation(s). For instance, application may be limited to only people in an inpatient setting, or not applicable for pregnant women. Conditional recommendations will always have conditions specified. Imperative recommendations may have some general conditions for application. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Potential Costs Associated with Application&lt;/strong&gt;: Includes any costs that may be associated with the application of this recommendation such as specialized staff, new equipment or treatments. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Recommendation Narrative&lt;/strong&gt;: Provides a brief description of the evidence that supports this recommendation. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;: Provides a brief list of the evidence strength and methodological issues that determined the recommendation strength. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Minority Opinions&lt;/strong&gt;: If the expert work group cannot reach consensus on the recommendation, the minority opinions may be listed here. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Supporting Evidence&lt;/strong&gt;: Provides links to the conclusions statements, evidence summaries and worksheets related to the formulation of this recommendation(s). &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;References Not Graded in the Academy's Evidence Analysis Process&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Recommendations are based on the summarized evidence from the analysis. Sources that are not analyzed during the evidence analysis process may be used to support and formulate the recommendation or to support information under other categories on the recommendation page, if the workgroup deems necessary. References must be credible resources (e.g., consensus reports, other guidelines, position papers, standards of practice, articles from peer-reviewed journals, nationally recognized documents or websites). If recommendations are based solely on these types of references, they will be rated as &quot;consensus.&quot;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Occasionally recommendations will include references that were not reviewed during the evidence analysis process but are relevant to the recommendation, risks and harms of implementing the recommendation, conditions of application, or potential costs associated with application. These references will be listed on the recommendation page under &quot;References Not Graded in the Academy's Evidence Analysis Process.&quot;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Complete the Writing of the Guideline&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Each disease-specific guideline has a similar format which incorporates the Introduction (includes: Scope of the Guideline, Statement of Intent, Guideline Methods, Implementation, Benefits and Risks/Harms of Implementation), Background Information and any necessary Appendices. The work group develops these features.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Criteria Used in Guideline Development&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The criteria used in determining the format and process for development of Academy's guidelines are based on the following tools and criteria for evidence-based guidelines:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Guideline Elements Model (GEM) which has been incorporated by the American Society for Testing and Materials (ASTM) as a Standard Specification for clinical practice guidelines. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;AGREE (Appraisal for Guidelines Research and Evaluation) Instrument &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;National Guideline Clearinghouse &lt;a href=&quot;http://www.guideline.gov&quot; title=&quot;NGC Web site&quot; target=&quot;_blank&quot;&gt;www.guideline.gov&lt;/a&gt; &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="146" OrdBy="450" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Criteria for Recommendation Rating&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Criteria for Recommendation Rating&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Statement Rating&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Implication for Practice&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Strong&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Strong&lt;/strong&gt; recommendation means that the workgroup believes that the benefits of the recommended approach clearly exceed the harms (or that the harms clearly exceed the benefits in the case of a strong negative recommendation), and that the quality of the supporting evidence is excellent/good (grade I or II).* In some clearly identified circumstances, strong recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits strongly outweigh the harms. &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should follow a &lt;strong&gt;Strong&lt;/strong&gt; recommendation unless a clear and compelling rationale for an alternative approach is present. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Fair&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Fair&lt;/strong&gt; recommendation means that the workgroup believes that the benefits exceed the harms (or that the harms clearly exceed the benefits in the case of a negative recommendation), but the quality of evidence is not as strong (grade II or III).* In some clearly identified circumstances, recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits outweigh the harms.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should generally follow a &lt;strong&gt;Fair&lt;/strong&gt; recommendation but remain alert to new information and be sensitive to patient preferences.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Weak&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Weak&lt;/strong&gt; recommendation means that the quality of evidence that exists is suspect or that well-done studies (grade I, II, or III)* show little clear advantage to one approach versus another.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should be cautious in deciding whether to follow a recommendation classified as &lt;strong&gt;Weak&lt;/strong&gt;, and should exercise judgment and be alert to emerging publications that report evidence. Patient preference should have a substantial influencing role. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Consensus&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Consensus&lt;/strong&gt; recommendation means that Expert opinion (grade IV) supports the guideline recommendation even though the available scientific evidence did not present consistent results, or controlled trials were lacking.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should be flexible in deciding whether to follow a recommendation classified as &lt;strong&gt;Consensus&lt;/strong&gt;, although they may set boundaries on alternatives. Patient preference should have a substantial influencing role. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Insufficient Evidence&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;An &lt;strong&gt;Insufficient Evidence&lt;/strong&gt; recommendation means that there is both a lack of pertinent evidence (grade V)* and/or an unclear balance between benefits and harms.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should feel little constraint in deciding whether to follow a recommendation labeled as &lt;strong&gt;Insufficient Evidence&lt;/strong&gt; and should exercise judgment and be alert to emerging publications that report evidence that clarifies the balance of benefit versus harm. Patient preference should have a substantial influencing role.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Conclusion statements are assigned a grade based on the strength of the evidence. Grade I is good; grade II, fair; grade III, limited; grade IV signifies expert opinion only and grade V indicates that a grade is not assignable because there is no evidence to support or refute the conclusion. The evidence and these grades are considered when assigning a rating (Strong, Fair, Weak, Consensus, Insufficient Evidence - see chart above) to a recommendation.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Adapted by the Academy of Nutrition and Dietetics (AND) from the American Academy of Pediatrics, Classifying Recommendations for Clinical Practice Guideline, Pediatrics. 2004;114;874-877. Revised by the AND Evidence-Based Practice Committee, Feb 2006.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="148" OrdBy="460" ID="417" Name="Cost Analysis" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="104" OrdBy="465" ID="418" Name="Method of Guideline Validation" Type="picklist-choice"><FieldValue Value="External Peer Review" /><FieldValue Value="Internal Peer Review" /></Field><Field FieldID="130" OrdBy="470" ID="419" Name="Description of Method of Guideline Validation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Each guideline is reviewed internally and externally using the AGREE (Appraisal of Guidelines for Research and Evaluation) Instrument as the evaluation tool. The external reviewers consist of an interdisciplinary group of individuals (may include dietitians, doctors, psychologists, nurses, etc.). The guideline is adjusted by consensus of the expert panel and approved by Academy's Evidence-Based Practice Committee prior to publication on the Evidence Analysis Library (EAL).&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="420" OrdBy="500" Name="Recommendations"><Field FieldID="151" OrdBy="505" ID="421" Name="Major Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Ratings for the strength of the recommendations (Strong, Fair, Weak, Consensus, Insufficient Evidence), conclusion grades (I-V), and statement labels (Conditional versus Imperative) are defined at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Food and Nutrition for Older Adults (FNOA): Weight Management in the Older Adult&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;FNOA: Considerations for Weight Management in the Older Adult&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Regardless of age, the registered dietitian (RD) should consider the following when assessing the need for weight management through modifications in dietary intake and physical activity in older adults:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Classification of overweight or obesity &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Presence of comorbidities &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Physical function &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Cognitive function &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Attitude toward longevity &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Lifestyle &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Personal choice &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Quality of life &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;While studies have demonstrated varying associations between assessment indicators of overweight or obesity and physical function and mortality in the older adult, the need for weight loss should be based on input from the physician or geriatrician, RD, qualified exercise specialist and other members of the health care team and will ultimately be the personal decision made by the older adult.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;FNOA: Use Multiple Assessment Indicators for Classification of Overweight/Obesity&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Regardless of age, the RD should use more than one of the following assessment indicators when classifying overweight or obesity:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Weight change (and weight history) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Current (and past) weight, height and body mass index (BMI) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Waist circumference &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Body composition &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;More than one assessment indicator should be used, due to the potential limitations of each indicator in the older adult, such as gender and ethnic differences in their application. In addition, studies demonstrated that muscle mass generally decreases and fat mass generally increases over time, even when weight is stable.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades I and II&lt;/strong&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;FNOA: United States Department of Agriculture (USDA) and Older Americans Act (OAA) Nutrition Service Programs for Older Adults&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;FNOA: Screen for USDA and OAA Program Eligibility&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The RD should screen all older adults for eligibility (or refer for screening) in USDA programs and the OAA Nutrition Service Program and identify potential barriers to participation, such as disability, functional impairment, attitude toward program utilization and income level. Research reported racial and ethnic differences in program participation, as well as in subjects with vision or hearing difficulties, special dietary needs, functional limitations or disabilities.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;FNOA: Encourage Participation in USDA and OAA Programs&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The RD should encourage eligible older adults to apply for and participate in the following USDA and OAA programs:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;USDA&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Supplemental Nutrition Assistance Program (SNAP) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Senior Farmer's Market Nutrition Program (SFMNP) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Child and Adult Care Food Program (CACFP) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Emergency Food Assistance Program &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Commodity Supplemental Food Program (CSFP) &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;OAA Programs&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;OAA Congregate Nutrition Program &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;OAA Home Delivered Nutrition Program &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Research reported that participation in USDA and OAA programs improved food and nutrient intake, increased fruit and vegetable consumption, stimulated interest in healthy foods, improved quality of life and improved nutritional status. However, some subjects felt that they did not need food assistance and some participants did not know that they were eligible or how to apply.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Fair&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grades II and III&lt;/strong&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;FNOA: Antioxidant Consumption and Age-Related Macular Degeneration and Cognitive Function in Older Adults&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;FNOA: Encourage Dietary Reference Intakes (DRI) for All Older Adults&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;For all older adults, the RD should encourage food intake meeting the Dietary Reference Intakes (or other recommended levels) for antioxidant vitamins and minerals and recommend a multi-vitamin if food intake is low. Studies regarding antioxidant intakes below recommended levels reported an association with cognitive decline, however, research regarding age-related macular degeneration was inconclusive.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Imperative&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;FNOA: Collaborate with Others Regarding Treatment of Diagnosed Age-Related Macular Degeneration&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;For older adults with diagnosed age-related macular degeneration, the RD should collaborate with others on the inter-professional team (such as physicians, ophthalmologists, pharmacists and other healthcare professionals) to determine whether an older adult would benefit from high-dose supplementation of antioxidants, as some formulations have side-effects and contraindications. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Studies have found a beneficial effect of antioxidant (beta-carotene, vitamin C and vitamin E), lutein/zeaxanthin and zinc and copper from diet or supplementation on delaying progression of advanced age-related macular degeneration. However, other studies report inconclusive findings. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;FNOA: Advise against Antioxidants for Treatment of Diagnosed Cognitive Impairment/Alzheimer's Disease&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;For older adults with diagnosed cognitive impairment or Alzheimer's disease, the RD should advise against antioxidant supplementation, as it has not been shown to have an effect and some formulations have side effects and contraindications. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Findings from studies of antioxidant intake above recommended dietary allowance (RDA) levels in subjects with diagnosed cognitive impairment or Alzheimer's disease demonstrated no difference in the delay of cognitive decline. These findings were substantiated by one systematic Cochrane review. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Strong&lt;/strong&gt;, Conditional&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation Strength Rationale&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Conclusion statements are &lt;strong&gt;Grade II&lt;/strong&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Definitions&lt;/strong&gt;&lt;/span&gt;:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Conditional vs Imperative Recommendations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Recommendations can be worded as &lt;em&gt;&lt;strong&gt;conditional&lt;/strong&gt;&lt;/em&gt; or &lt;strong&gt;&lt;em&gt;imperative&lt;/em&gt;&lt;/strong&gt; statements. Conditional statements clearly define a specific situation, while imperative statements are broadly applicable to the target population without restraints on their pertinence. More specifically, a conditional recommendation can be stated in if/then terminology (e.g., If an individual does not eat food sources of omega-3 fatty acids, then 1g of EPA and DHA omega-3 fatty acid supplements &lt;em&gt;may&lt;/em&gt; be recommended for secondary prevention).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In contrast, imperative recommendations &quot;require,&quot; or &quot;must,&quot; or &quot;should achieve certain goals,&quot; but do not contain conditional text that would limit their applicability to specified circumstances. (e.g., Portion control should be included as part of a comprehensive weight management program. Portion control at meals and snacks results in reduced energy intake and weight loss).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Conclusion Grading Table&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Conclusion Grading Table&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Strength of Evidence Elements&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade I&lt;br /&gt;&#xD;&#xA;            Good/Strong&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade II&lt;br /&gt;&#xD;&#xA;            Fair&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade III&lt;br /&gt;&#xD;&#xA;            Limited/Weak&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade IV&lt;br /&gt;&#xD;&#xA;            Expert Opinion Only&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Grade V&lt;br /&gt;&#xD;&#xA;            Grade Not Assignable&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Quality&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Scientific rigor/validity &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Considers design and execution &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of strong design for question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Free from design flaws, bias and execution problems &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of strong design for question with minor methodological concerns&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Only studies of weaker study design for question&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studies of weak design for answering the question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Inconclusive findings due to design flaws, bias or execution problems&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No studies available&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Conclusion based on usual practice, expert consensus, clinical experience, opinion, or extrapolation from basic research &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;No evidence that pertains to question being addressed &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Consistency&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Of findings across studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Findings generally consistent in direction and size of effect or degree of association, and statistical significance with minor exceptions at most&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Inconsistency among results of studies with strong design&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Consistency with minor exceptions across studies of weaker designs&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Unexplained inconsistency among results from different studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Single study unconfirmed by other studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Conclusion supported solely by statements of informed nutrition or medical commentators&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;NA&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Quantity&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Number of studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Number of subjects in studies &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;One to several good quality studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Large number of subjects studied&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Studies with negative results having sufficiently large sample size for adequate statistical power&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Several studies by independent investigators&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Doubts about adequacy of sample size to avoid Type I and Type II error &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Limited number of studies&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Low number of subjects studied and/or inadequate sample size within studies &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Unsubstantiated by published studies&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Relevant studies have not been done&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Clinical Impact&lt;/strong&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Importance of studied outcomes &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Magnitude of effect &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied outcome relates directly to the question&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Size of effect is clinically meaningful&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Significant (statistical) difference is large &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Some doubt about the statistical or clinical significance of effect&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied outcome is an intermediate outcome or surrogate for the true outcome of interest&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            OR&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            Size of effect is small or lacks statistical and/or clinical significance&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Objective data unavailable&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Indicates area for future research&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&lt;strong&gt;Generalizability&lt;/strong&gt;&lt;br /&gt;&#xD;&#xA;            &lt;br /&gt;&#xD;&#xA;            To population of interest&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Studied population, intervention and outcomes are free from serious doubts about generalizability&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Minor doubts about generalizability&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Serious doubts about generalizability due to narrow or different study population, intervention or outcomes studied&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Generalizability limited to scope of experience&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;NA&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;This grading system was based on the grading system from Greer, Mosser, Logan, &amp;amp; Wagstrom Halaas. A practical approach to evidence grading. Jt Comm J Qual Improv. 2000;26:700-712. In September 2004, The ADA Research Committee modified the grading system to this current version.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Criteria for Recommendation Rating&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;1&quot; cellpadding=&quot;3&quot; summary=&quot;Table: Criteria for Recommendation Rating&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Statement Rating&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Definition&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot;&gt;Implication for Practice&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Strong&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Strong&lt;/strong&gt; recommendation means that the workgroup believes that the benefits of the recommended approach clearly exceed the harms (or that the harms clearly exceed the benefits in the case of a strong negative recommendation), and that the quality of the supporting evidence is excellent/good (grade I or II).* In some clearly identified circumstances, strong recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits strongly outweigh the harms. &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should follow a &lt;strong&gt;Strong&lt;/strong&gt; recommendation unless a clear and compelling rationale for an alternative approach is present. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Fair&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Fair&lt;/strong&gt; recommendation means that the workgroup believes that the benefits exceed the harms (or that the harms clearly exceed the benefits in the case of a negative recommendation), but the quality of evidence is not as strong (grade II or III).* In some clearly identified circumstances, recommendations may be made based on lesser evidence when high-quality evidence is impossible to obtain and the anticipated benefits outweigh the harms.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should generally follow a &lt;strong&gt;Fair&lt;/strong&gt; recommendation but remain alert to new information and be sensitive to patient preferences.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Weak&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Weak&lt;/strong&gt; recommendation means that the quality of evidence that exists is suspect or that well-done studies (grade I, II, or III)* show little clear advantage to one approach versus another.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should be cautious in deciding whether to follow a recommendation classified as &lt;strong&gt;Weak&lt;/strong&gt;, and should exercise judgment and be alert to emerging publications that report evidence. Patient preference should have a substantial influencing role. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Consensus&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A &lt;strong&gt;Consensus&lt;/strong&gt; recommendation means that Expert opinion (grade IV) supports the guideline recommendation even though the available scientific evidence did not present consistent results, or controlled trials were lacking.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should be flexible in deciding whether to follow a recommendation classified as &lt;strong&gt;Consensus&lt;/strong&gt;, although they may set boundaries on alternatives. Patient preference should have a substantial influencing role. &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th valign=&quot;top&quot;&gt;Insufficient Evidence&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;An &lt;strong&gt;Insufficient Evidence&lt;/strong&gt; recommendation means that there is both a lack of pertinent evidence (grade V)* and/or an unclear balance between benefits and harms.&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Practitioners should feel little constraint in deciding whether to follow a recommendation labeled as &lt;strong&gt;Insufficient Evidence&lt;/strong&gt; and should exercise judgment and be alert to emerging publications that report evidence that clarifies the balance of benefit versus harm. Patient preference should have a substantial influencing role.&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Conclusion statements are assigned a grade based on the strength of the evidence. Grade I is good; grade II, fair; grade III, limited; grade IV signifies expert opinion only and grade V indicates that a grade is not assignable because there is no evidence to support or refute the conclusion. The evidence and these grades are considered when assigning a rating (Strong, Fair, Weak, Consensus, Insufficient Evidence - see chart above) to a recommendation.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Adapted by the Academy of Nutrition and Dietetics (AND) from the American Academy of Pediatrics, Classifying Recommendations for Clinical Practice Guideline, Pediatrics. 2004;114;874-877. Revised by the AND Evidence-Based Practice Committee, Feb 2006.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="138" OrdBy="515" ID="423" Name="Clinical Algorithm(s)" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations"><Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see the &quot;Major Recommendations&quot; field).&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The guideline contains conclusion statements that are supported by evidence summaries and evidence worksheets. These resources summarize the important studies (randomized controlled trials [RCTs], clinical studies, observational studies, cohort and case-control studies) pertaining to the conclusion statement and provide the study details.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations"><Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;A primary goal of implementing these recommendations includes improving a person's ability to achieve optimal nutrition through healthful food choices and a physically-active lifestyle. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Although costs of medical nutrition therapy (MNT) sessions and reimbursement vary, MNT is essential for improved outcomes. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;MNT education can be considered cost-effective when considering the benefits of nutrition interventions on the onset and progression of comorbidities versus the cost of the intervention. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field><Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;Overall Risk/Harm Considerations&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Safety issues must be reviewed carefully for each individual. When using these recommendations, consider the following general risks and harms:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Review the patient's age, socio-economic status, cultural issues, health history and other health conditions. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Consider referral to a behavioral specialist if psycho-social issues are a concern. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Consider a referral to social services to assist patients with financial arrangements if economic issues are a concern. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Use clinical judgment in applying the guidelines. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Recommendation-Specific Risks/Harms&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Potential Harms Identified by the National Institutes of Health (NIH) State-of-the-Science Conference Statement on Multi-vitamin/Mineral Supplements and Chronic Disease Prevention&lt;/em&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;There is evidence that certain ingredients in multi-vitamin/mineral (MVM) supplements can produce adverse effects, including reports from randomized controlled trials (RCTs) that noted excess lung cancer occurring in asbestos workers and smokers consuming beta-carotene. In addition, esophageal cancer excess was found with long-term follow-up of older Chinese patients treated with selenium, beta-carotene and vitamin E supplements. There was also evidence for gender difference in patterns of lung cancer and cardiovascular disease risk related to beta-carotene. In another study, patients with elevated prostate-specific antigen levels at baseline who were receiving an MVM intervention had higher incidence of prostate cancer. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Vitamin D and calcium may increase the risk for kidney stones for certain people. These data raise safety questions both in general and in special populations. Although these studies are not definitive, they do suggest possible safety concerns that should be monitored for primary components of multi-vitamins. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;There is potential for adverse effects in individuals consuming dietary supplements that are above the upper level. This can occur, not only in individuals consuming high-potency single-nutrient supplements, but also in individuals who consume a healthy diet rich in fortified foods, in combination with MVM supplements. Furthermore, by law, the listing of ingredient amounts on nutrient supplement labels is the minimum content, thus higher intakes are probable. Data from prospective studies have shown that individuals taking MVM dietary supplements improved their nutritional adequacy with respect to several nutrients, but also increased the proportion of their intakes above the upper level for several of the supplemented nutrients. With the strong trends of increasing MVM and other dietary supplement consumption and the increasing fortification of the US diet, the guideline developers are concerned that a growing proportion of the population may be consuming levels considerably above the upper level, thus increasing the possibility of adverse effects. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field></Section><Section SecID="432" OrdBy="900" Name="Qualifying Statements"><Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text"><FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;While the evidence-based nutrition practice guidelines represent a statement of best practice based on the latest available evidence at the time of publishing, they are not intended to overrule professional judgment. Rather, they may be viewed as a relative constraint on individual clinician discretion in a particular clinical circumstance. The independent skill and judgment of the health care provider must always dictate treatment decisions. These nutrition practice guidelines are provided with the express understanding that they do not establish or specify particular standards of care, whether legal, medical or other. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;This nutrition practice guideline is meant to serve as a general framework for handling clients with particular health problems. It may not always be appropriate to use these nutrition practice guidelines to manage clients because individual circumstances may vary. For example, different treatments may be appropriate for clients who are severely ill or who have co-morbid, socioeconomic, or other complicating conditions. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;The Role of Patient Preference&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;This guideline recognizes the role of patient preferences for possible outcomes of care, when the appropriateness of a clinical intervention involves a substantial element of personal choice or values. With regard to types of evidence that are associated with particular outcomes, two major classes have been described. Patient-oriented evidence that matters (POEM) deals with outcomes of importance to patients, such as changes in morbidity, mortality or quality of life. Disease-oriented evidence (DOE) deals with surrogate end-points, such as changes in laboratory values or other measures of response. Although the results of DOE sometimes parallel the results of POEM, they do not always correspond. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;When possible, the Academy of Nutrition and Dietetics recommends using POEM-type evidence rather than DOE. When DOE is the only guidance available, the guideline indicates that key clinical recommendations lack the support of outcomes evidence. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" /></Field></Section><Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline"><Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The publication of these recommendations is an integral part of the plans for getting the Academy of Nutrition and Dietetics evidence-based recommendations on critical illness to all dietetics practitioners engaged in, teaching about, or researching critical illness as quickly as possible. National implementation workshops at various sites around the country and during the Academy Food Nutrition Conference Expo (FNCE) are planned. Additionally, there are recommended dissemination and adoption strategies for local use.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The recommendation development team recommended multi-faceted strategies to disseminate the guideline and encourage its implementation. Management support and learning through social influence are likely to be effective in implementing guidelines in dietetic practice. However, additional interventions may be needed to achieve real change in practice routines.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Implementation of the recommendations will be achieved by announcement at professional events, presentations and training. Some strategies include:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;National and Local Events&lt;/strong&gt; &amp;ndash; State dietetic association meetings and media coverage will help launch the guideline. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Local Feedback Adaptation&lt;/strong&gt; &amp;ndash; Presentation by members of the work group at peer review meetings and opportunities for continuing education units (CEUs) for courses completed &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Education Initiatives&lt;/strong&gt; &amp;ndash; The recommendations will be freely available for use in the education and training of dietetic interns and students in approved Commission on Accreditation of Dietetics Education (CADE) programs. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Champions&lt;/strong&gt; &amp;ndash; Local champions have been identified and expert members of the recommendation team will prepare articles for publications. Resources will be provided that include PowerPoint presentations and pre-prepared case studies. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;&lt;strong&gt;Practical Tools&lt;/strong&gt; &amp;ndash; Some of the tools that will be developed to help implement the guideline include specially designed resources such as slide presentations and training webinars. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p&gt;Specific distribution strategies include:&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Publication in Full&lt;/strong&gt; &amp;ndash; The recommendations are available electronically at the &lt;a href=&quot;http://www.andevidencelibrary.com&quot; title=&quot;Academy of Nutrition and Dietetics Evidence Analysis Library Web site&quot;&gt;Academy of Nutrition and Dietetics Evidence Analysis Library Web site&lt;/a&gt; and announced to all Academy Dietetic Practice Groups. The Academy's Evidence Analysis Library will also provide downloadable supporting information and links to relevant position papers.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many"><FieldValue Value="Quick Reference Guides/Physician Guides" /><FieldValue Value="Slide Presentation" /></Field></Section><Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories"><Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many"><FieldValue Value="Getting Better" /><FieldValue Value="Living with Illness" /><FieldValue Value="Staying Healthy" /></Field><Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many"><FieldValue Value="Effectiveness" /><FieldValue Value="Patient-centeredness" /></Field></Section><Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability"><Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation"><FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Academy of Nutrition and Dietetics. Food and nutrition for older adults promoting health and wellness. Chicago (IL): Academy of Nutrition and Dietetics; 2012. Various p. &lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" /></Field><Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text"><FieldValue Value="2012" /></Field><Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p"><FieldValue Value="Academy of Nutrition and Dietetics - Professional Association" /></Field><Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The Academy acknowledges and is grateful for support from financial contributors; however the Academy's Research and Strategic Business Development staff maintains full control over the content and process of all evidence analysis projects including the selection of topics, evaluation of research, assignment of grades, and development of recommendations.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Food and Nutrition for Older Adults Promoting Health and Wellness Expert Work Group&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Workgroup Members&lt;/em&gt;: Nancy M. Munoz, MHA, DCN, RD, LDN (&lt;em&gt;Chair&lt;/em&gt;); Melissa A. Bernstein, PhD, RD, LD; Joan G. Fischer, PhD, RD; Kathleen T. Morgan, Dr. M.H., DTR; Susan Saffel-Shrier, MS, RD, CD; Edward H. Weiss, PhD, RD&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;In the interest of full disclosure, the Academy has adopted the policy of revealing relationships work group members have with companies that sell products or services that are relevant to this guideline topic. Work group members are required to disclose potential conflicts of interest by completing the Academy Conflict of Interest Form. It should not be assumed that these financial interests will have an adverse impact on the content of the guideline, but they are noted here to fully inform readers.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;No work group members have potential conflicts of interest to disclose.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Electronic copies: Available to members from the &lt;a href=&quot;http://andevidencelibrary.com/topic.cfm?cat=4879&quot; title=&quot;Academy of Nutrition and Dietetics Web site&quot;&gt;Academy of Nutrition and Dietetics Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Academy of Nutrition and Dietetics food and nutrition for older adults promoting health and wellness (FNOA) guideline. Executive summary of recommendations. Chicago (IL): Academy of Nutrition and Dietetics; 2012. Available from the &lt;a href=&quot;http://andevidencelibrary.com/topic.cfm?cat=4880&quot; title=&quot;Academy of Nutrition and Dietetics (AND) Web site&quot;&gt;Academy of Nutrition and Dietetics (AND) Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Academy of Nutrition and Dietetics food and nutrition for older adults promoting health and wellness (FNOA) guideline presentation. Slide set. 29 p. Chicago (IL): Academy of Nutrition and Dietetics; 2012. Electronic copies: Available for purchase from the &lt;a href=&quot;https://andevidencelibrary.com/store.cfm?category=5&quot; title=&quot;Academy of Nutrition and Dietetics (AND) Web site&quot;&gt;AND Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" /></Field><Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None available&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on March 25, 2013.&lt;/p&gt;&lt;/div&gt;" /></Field><Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text"><FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The Academy of Nutrition and Dietetics encourages the free exchange of evidence in nutrition practice guidelines and promotes the adaptation of the guidelines for local conditions. However, please note that guidelines are subject to copyright provisions. To replicate or reproduce this guideline, in part or in full, please obtain agreement from the Academy of Nutrition and Dietetics. Please contact Kari Kren at &lt;a href=&quot;mailto:kkren@eatright.org&quot;&gt;kkren@eatright.org&lt;/a&gt; for copyright permission.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;When modifying the guidelines for local circumstances, significant departures from these comprehensive guidelines should be fully documented and the reasons for the differences explicitly detailed.&lt;/p&gt;&lt;/div&gt;" /></Field></Section><Section SecID="99999" OrdBy="99999" Name="Disclaimer"><Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text"><FieldValue Value="&lt;p&gt;The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at &lt;a href=&quot;/about/inclusion-criteria.aspx&quot;&gt;http://www.guideline.gov/about/inclusion-criteria.aspx&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" /></Field></Section></Version>
